{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:16Z","timestamp":1792788256680,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Senior Medical Talents Program of Chongqing for Young and Middle-aged","award":["YXGD202472"],"award-info":[{"award-number":["YXGD202472"]}]},{"name":"National Natural Science Foundation of China","award":["82272024"],"award-info":[{"award-number":["82272024"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04079-w","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:45:16Z","timestamp":1769971516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HIFU postoperative hypoxia-activated metal-organic frameworks modulate the tumor microenvironment to augment immunotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Chengyan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiji","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"issue":"1","key":"4079_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"4079_CR2","doi-asserted-by":"publisher","first-page":"1037959","DOI":"10.3389\/fonc.2022.1037959","volume":"12","author":"NM deSouza","year":"2022","unstructured":"deSouza NM, Gedroyc W, Rivens I, Ter Haar G. Tissue specific considerations in implementing high intensity focussed ultrasound under magnetic resonance imaging guidance. Front Oncol. 2022;12:1037959.","journal-title":"Front Oncol"},{"key":"4079_CR3","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.2147\/IJN.S315650","volume":"16","author":"Y Tang","year":"2021","unstructured":"Tang Y, Chen C, Jiang B, Wang L, Jiang F, Wang D, Wang Y, Yang H, Ou X, Du Y, et al. Bifidobacterium bifidum-Mediated specific delivery of nanoparticles for tumor therapy. Int J Nanomed. 2021;16:4643\u201359.","journal-title":"Int J Nanomed"},{"key":"4079_CR4","doi-asserted-by":"publisher","first-page":"106798","DOI":"10.1016\/j.ultsonch.2024.106798","volume":"103","author":"H Jiao","year":"2024","unstructured":"Jiao H, Mao Q, Razzaq N, Ankri R, Cui J. Ultrasound technology assisted colloidal nanocrystal synthesis and biomedical applications. Ultrason Sonochem. 2024;103:106798.","journal-title":"Ultrason Sonochem"},{"issue":"5","key":"4079_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1158\/1078-0432.CCR-19-1604","volume":"26","author":"A Eranki","year":"2020","unstructured":"Eranki A, Srinivasan P, Ries M, Kim A, Lazarski CA, Rossi CT, Khokhlova TD, Wilson E, Knoblach SM, Sharma KV, et al. High-Intensity focused ultrasound (HIFU) triggers immune sensitization of refractory murine neuroblastoma to checkpoint inhibitor therapy. Clin Cancer Res. 2020;26(5):1152\u201361.","journal-title":"Clin Cancer Res"},{"key":"4079_CR6","doi-asserted-by":"publisher","first-page":"120639","DOI":"10.1016\/j.biomaterials.2020.120639","volume":"269","author":"H Chen","year":"2021","unstructured":"Chen H, Liu L, Ma A, Yin T, Chen Z, Liang R, Qiu Y, Zheng M, Cai L. Noninvasively Immunogenic sonodynamic therapy with manganese protoporphyrin liposomes against triple-negative breast cancer. Biomaterials. 2021;269:120639.","journal-title":"Biomaterials"},{"key":"4079_CR7","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2147\/IJN.S297933","volume":"16","author":"Y Si","year":"2021","unstructured":"Si Y, Yue J, Liu Z, Li M, Du F, Wang X, Dai Z, Hu N, Ju J, Gao S, et al. Phase-Transformation Nanoparticle-Mediated sonodynamic therapy: an effective modality to enhance anti-Tumor immune response by inducing Immunogenic cell death in breast cancer. Int J Nanomed. 2021;16:1913\u201326.","journal-title":"Int J Nanomed"},{"issue":"2","key":"4079_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00262-016-1891-9","volume":"66","author":"RJ van den Bijgaart","year":"2017","unstructured":"van den Bijgaart RJ, Eikelenboom DC, Hoogenboom M, F\u00fctterer JJ, den Brok MH, Adema GJ. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. Cancer Immunol Immunother. 2017;66(2):247\u201358.","journal-title":"Cancer Immunol Immunother"},{"issue":"23","key":"4079_CR9","doi-asserted-by":"publisher","first-page":"26808","DOI":"10.1021\/acsami.1c07494","volume":"13","author":"Q Li","year":"2021","unstructured":"Li Q, Zhang J, Li J, Ye H, Li M, Hou W, Li H, Wang Z. Glutathione-Activated NO-\/ROS-Generation nanoparticles to modulate the tumor hypoxic microenvironment for enhancing the effect of HIFU-Combined chemotherapy. ACS Appl Mater Interfaces. 2021;13(23):26808\u201323.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4079_CR10","doi-asserted-by":"publisher","first-page":"100926","DOI":"10.1016\/j.mtbio.2023.100926","volume":"24","author":"X Xie","year":"2024","unstructured":"Xie X, Zhang J, Wang Y, Shi W, Tang R, Tang Q, Sun S, Wu R, Xu S, Wang M, et al. Nanomaterials augmented bioeffects of ultrasound in cancer immunotherapy. Mater Today Bio. 2024;24:100926.","journal-title":"Mater Today Bio"},{"key":"4079_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2022.03.008","volume":"345","author":"F Mpekris","year":"2022","unstructured":"Mpekris F, Voutouri C, Panagi M, Baish JW, Jain RK, Stylianopoulos T. Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy. J Control Release. 2022;345:190\u20139.","journal-title":"J Control Release"},{"issue":"29","key":"4079_CR12","doi-asserted-by":"publisher","first-page":"2010777","DOI":"10.1002\/adfm.202010777","volume":"31","author":"R Lima-Sousa","year":"2021","unstructured":"Lima-Sousa R, Melo BL, Alves CG, Moreira AF, Mendon\u00e7a AG, Correia IJ, de Melo-Diogo D. Combining Photothermal-Photodynamic therapy mediated by nanomaterials with immune checkpoint Blockade for metastatic cancer treatment and creation of immune memory. Adv Funct Mater. 2021;31(29):2010777.","journal-title":"Adv Funct Mater"},{"issue":"28","key":"4079_CR13","doi-asserted-by":"publisher","first-page":"18412","DOI":"10.1021\/acsnano.4c02921","volume":"18","author":"J Li","year":"2024","unstructured":"Li J, Luo C, Sun T, Zhou Y, Huang X, Wu D, Luo X, Zeng C, Li H. Hypoxia-Specific Metal-Organic frameworks augment cancer immunotherapy of High-Intensity focused ultrasound. ACS Nano. 2024;18(28):18412\u201324.","journal-title":"ACS Nano"},{"issue":"18","key":"4079_CR14","doi-asserted-by":"publisher","first-page":"e2306338","DOI":"10.1002\/smll.202306338","volume":"20","author":"T Sun","year":"2024","unstructured":"Sun T, Li J, Zhou Y, Zeng C, Luo C, Luo X, Li H. Metal-Organic Framework-Mediated synergistic Hypoxia-Activated Chemo-Immunotherapy induced by high intensity focused ultrasound for enhanced cancer theranostics. Small. 2024;20(18):e2306338.","journal-title":"Small"},{"key":"4079_CR15","doi-asserted-by":"publisher","first-page":"101885","DOI":"10.1016\/j.redox.2021.101885","volume":"41","author":"JM Mart\u00ed","year":"2021","unstructured":"Mart\u00ed JM, Garcia-Diaz A, Delgado-Bellido D, O\u2019Valle F, Gonz\u00e1lez-Flores A, Carlevaris O, Rodr\u00edguez-Vargas JM, Am\u00e9 JC, Dantzer F, King GL, et al. Selective modulation by PARP-1 of HIF-1\u03b1-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions. Redox Biol. 2021;41:101885.","journal-title":"Redox Biol"},{"key":"4079_CR16","doi-asserted-by":"crossref","unstructured":"Tang R, He H, Lin X, Wu N, Wan L, Chen Q, Hu Y, Cheng C, Cao Y, Guo X et al. Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy. J Immunother Cancer 2023;11(1).","DOI":"10.1136\/jitc-2022-006226"},{"issue":"12","key":"4079_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1054\/bjoc.2000.1564","volume":"83","author":"LH Patterson","year":"2000","unstructured":"Patterson LH, McKeown SR. AQ4N: a new approach to hypoxia-activated cancer chemotherapy. Br J Cancer. 2000;83(12):1589\u201393.","journal-title":"Br J Cancer"},{"issue":"11","key":"4079_CR18","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1182\/blood.V104.11.2498.2498","volume":"104","author":"JL Cleland","year":"2004","unstructured":"Cleland JL, Wong A, Alters SE, Harris PA, Dunk CR, Curd JG, Capizzi RL, Henner WD. A novel N-Oxide Drug, AQ4N, has in vitro activity in lymphoma and leukemia cell lines and selectively targets lymphocytes and lymphatic tissues in vivo. Blood. 2004;104(11):2498\u20132498.","journal-title":"Blood"},{"issue":"2","key":"4079_CR19","doi-asserted-by":"publisher","first-page":"e2202348","DOI":"10.1002\/adhm.202202348","volume":"12","author":"T Sun","year":"2023","unstructured":"Sun T, Li J, Zeng C, Luo C, Luo X, Li H. Banoxantrone coordinated Metal-Organic framework for photoacoustic Imaging-Guided high intensity focused ultrasound therapy. Adv Healthc Mater. 2023;12(2):e2202348.","journal-title":"Adv Healthc Mater"},{"key":"4079_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.semcancer.2019.12.021","volume":"65","author":"LC Dieterich","year":"2020","unstructured":"Dieterich LC, Bikfalvi A. The tumor organismal environment: role in tumor development and cancer immunotherapy. Semin Cancer Biol. 2020;65:197\u2013206.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4079_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","volume":"29","author":"A Tiwari","year":"2022","unstructured":"Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci. 2022;29(1):83.","journal-title":"J Biomed Sci"},{"issue":"1","key":"4079_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-020-02366-0","volume":"18","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wu J, Huang W, Weng S, Wang B, Chen Y, Wang H. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. J Transl Med. 2020;18(1):201.","journal-title":"J Transl Med"},{"issue":"1","key":"4079_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","volume":"20","author":"EE Abd El-Fattah","year":"2022","unstructured":"Abd El-Fattah EE. IDO\/kynurenine pathway in cancer: possible therapeutic approaches. J Transl Med. 2022;20(1):347.","journal-title":"J Transl Med"},{"key":"4079_CR24","doi-asserted-by":"publisher","unstructured":"Krupa A, Kowalska I. The kynurenine Pathway-New linkage between innate and adaptive immunity in autoimmune endocrinopathies. Int J Mol Sci 2021, 22(18):9879. https:\/\/doi.org\/10.3390\/ijms22189879","DOI":"10.3390\/ijms22189879"},{"key":"4079_CR25","doi-asserted-by":"publisher","first-page":"120970","DOI":"10.1016\/j.biomaterials.2021.120970","volume":"275","author":"L Zhao","year":"2021","unstructured":"Zhao L, Zheng R, Liu L, Chen X, Guan R, Yang N, Chen A, Yu X, Cheng H, Li S. Self-delivery oxidative stress amplifier for chemotherapy sensitized immunotherapy. Biomaterials. 2021;275:120970.","journal-title":"Biomaterials"},{"issue":"1","key":"4079_CR26","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41467-017-01725-8","volume":"8","author":"A Lewis-Ballester","year":"2017","unstructured":"Lewis-Ballester A, Pham KN, Batabyal D, Karkashon S, Bonanno JB, Poulos TL, Yeh SR. Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1. Nat Commun. 2017;8(1):1693.","journal-title":"Nat Commun"},{"issue":"9","key":"4079_CR27","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1021\/acsanm.5c00589","volume":"8","author":"L Menilli","year":"2025","unstructured":"Menilli L, Milani C, Martella E, Tubertini M, Tedesco D, Guerrini A, Baschieri A, Costa B, Moret F, Ferroni C, et al. Paclitaxel and Nlg919 Co-loaded MnO2\u2013Albumin nanoparticles for synergistic chemoimmune cancer therapy. ACS Appl Nano Mater. 2025;8(9):4911\u201325.","journal-title":"ACS Appl Nano Mater"},{"issue":"3","key":"4079_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","volume":"58","author":"A Llibre","year":"2025","unstructured":"Llibre A, Kucuk S, Gope A, Certo M, Mauro C. Lactate: A key regulator of the immune response. Immunity. 2025;58(3):535\u201354.","journal-title":"Immunity"},{"issue":"9","key":"4079_CR29","doi-asserted-by":"publisher","first-page":"13884","DOI":"10.1021\/acsnano.2c02688","volume":"16","author":"Z Dong","year":"2022","unstructured":"Dong Z, Wang C, Gong Y, Zhang Y, Fan Q, Hao Y, Li Q, Wu Y, Zhong X, Yang K, et al. Chemical modulation of glucose metabolism with a fluorinated CaCO(3) nanoregulator can potentiate radiotherapy by programming antitumor immunity. ACS Nano. 2022;16(9):13884\u201399.","journal-title":"ACS Nano"},{"issue":"11","key":"4079_CR30","doi-asserted-by":"publisher","first-page":"18921","DOI":"10.1021\/acsnano.2c07818","volume":"16","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cui Y, Cao W, Zhao M, Lin W, Xu R, Xu Y, Chen Y, Li H, Liang J, et al. Nanohydroxyapatite stimulates PD-L1 expression to boost melanoma combination immunotherapy. ACS Nano. 2022;16(11):18921\u201335.","journal-title":"ACS Nano"},{"issue":"52","key":"4079_CR31","doi-asserted-by":"publisher","first-page":"e2103072","DOI":"10.1002\/smll.202103072","volume":"17","author":"Y Cai","year":"2021","unstructured":"Cai Y, Chen X, Si J, Mou X, Dong X. All-in-One nanomedicine: multifunctional Single-Component nanoparticles for cancer theranostics. Small. 2021;17(52):e2103072.","journal-title":"Small"},{"issue":"12","key":"4079_CR32","doi-asserted-by":"publisher","first-page":"e1907152","DOI":"10.1002\/adma.201907152","volume":"32","author":"B Yang","year":"2020","unstructured":"Yang B, Ding L, Yao H, Chen Y, Shi J. A Metal-Organic framework (MOF) Fenton Nanoagent-Enabled nanocatalytic cancer therapy in synergy with autophagy Inhibition. Adv Mater. 2020;32(12):e1907152.","journal-title":"Adv Mater"},{"issue":"1","key":"4079_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, Meng Q, Yu X, Shi S. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(1):110.","journal-title":"J Hematol Oncol"},{"issue":"43","key":"4079_CR34","doi-asserted-by":"publisher","first-page":"e2302758","DOI":"10.1002\/smll.202302758","volume":"19","author":"Z Chen","year":"2023","unstructured":"Chen Z, Li Z, Huang H, Shen G, Ren Y, Mao X, Wang L, Li Z, Wang W, Li G, et al. Cancer immunotherapy based on cell Membrane-Coated nanocomposites augmenting cGAS\/STING activation by efferocytosis Blockade. Small. 2023;19(43):e2302758.","journal-title":"Small"},{"issue":"3","key":"4079_CR35","doi-asserted-by":"publisher","first-page":"e2208277","DOI":"10.1002\/adma.202208277","volume":"35","author":"M Zhan","year":"2023","unstructured":"Zhan M, Qiu J, Fan Y, Chen L, Guo Y, Wang Z, Li J, Majoral JP, Shi X. Phosphorous dendron micelles as a nanomedicine platform for cooperative tumor chemoimmunotherapy via synergistic modulation of immune cells. Adv Mater. 2023;35(3):e2208277.","journal-title":"Adv Mater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04079-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04079-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04079-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:41:16Z","timestamp":1791308476000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04079-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4079"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04079-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Ethical Committee for Laboratory Animals of Chongqing Medical University (Approval No. 2022156).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"200"}}